nodes	percent_of_prediction	percent_of_DWPC	metapath
Phenobarbital—CYP2C18—prostate cancer	0.074	0.21	CbGaD
Phenobarbital—CYP1B1—prostate cancer	0.0612	0.174	CbGaD
Phenobarbital—CYP3A5—prostate cancer	0.0487	0.138	CbGaD
Phenobarbital—CYP2A6—prostate cancer	0.0472	0.134	CbGaD
Phenobarbital—CYP4A11—Estrone—prostate cancer	0.0421	0.0948	CbGbCtD
Phenobarbital—CYP2E1—prostate cancer	0.0335	0.0952	CbGaD
Phenobarbital—CYP2C19—prostate cancer	0.0332	0.0942	CbGaD
Phenobarbital—CYP1A1—prostate cancer	0.033	0.0939	CbGaD
Phenobarbital—CYP1B1—Flutamide—prostate cancer	0.0242	0.0544	CbGbCtD
Phenobarbital—CYP3A4—prostate cancer	0.0211	0.0599	CbGaD
Phenobarbital—CYP1B1—Estrone—prostate cancer	0.0175	0.0394	CbGbCtD
Phenobarbital—ABCC1—Abiraterone—prostate cancer	0.0172	0.0387	CbGbCtD
Phenobarbital—ABCB11—Ethinyl Estradiol—prostate cancer	0.0156	0.0351	CbGbCtD
Phenobarbital—ABCC3—Conjugated Estrogens—prostate cancer	0.0132	0.0298	CbGbCtD
Phenobarbital—CYP1A1—Flutamide—prostate cancer	0.0106	0.0239	CbGbCtD
Phenobarbital—CYP1B1—Mitoxantrone—prostate cancer	0.0104	0.0234	CbGbCtD
Phenobarbital—CYP1B1—Estradiol—prostate cancer	0.01	0.0226	CbGbCtD
Phenobarbital—ABCC2—Ethinyl Estradiol—prostate cancer	0.0082	0.0184	CbGbCtD
Phenobarbital—ABCC1—Conjugated Estrogens—prostate cancer	0.00813	0.0183	CbGbCtD
Phenobarbital—CYP1A1—Estrone—prostate cancer	0.00767	0.0173	CbGbCtD
Phenobarbital—ABCC3—Etoposide—prostate cancer	0.00759	0.0171	CbGbCtD
Phenobarbital—CYP2C8—Nilutamide—prostate cancer	0.00739	0.0166	CbGbCtD
Phenobarbital—ABCC1—Mitoxantrone—prostate cancer	0.00739	0.0166	CbGbCtD
Phenobarbital—CYP3A5—Flutamide—prostate cancer	0.00637	0.0143	CbGbCtD
Phenobarbital—CYP2C19—Bicalutamide—prostate cancer	0.0062	0.014	CbGbCtD
Phenobarbital—CYP2C19—Nilutamide—prostate cancer	0.0062	0.014	CbGbCtD
Phenobarbital—CYP2C8—Abiraterone—prostate cancer	0.00613	0.0138	CbGbCtD
Phenobarbital—ABCC2—Conjugated Estrogens—prostate cancer	0.00602	0.0135	CbGbCtD
Phenobarbital—CYP1B1—Docetaxel—prostate cancer	0.006	0.0135	CbGbCtD
Phenobarbital—ABCC1—Epirubicin—prostate cancer	0.00598	0.0135	CbGbCtD
Phenobarbital—CYP2E1—Estrone—prostate cancer	0.00593	0.0133	CbGbCtD
Phenobarbital—CYP2B6—Estrone—prostate cancer	0.00585	0.0132	CbGbCtD
Phenobarbital—CYP3A4—Estradiol valerate/Dienogest—prostate cancer	0.00571	0.0128	CbGbCtD
Phenobarbital—CYP2B6—Ethinyl Estradiol—prostate cancer	0.00521	0.0117	CbGbCtD
Phenobarbital—ABCC3—Doxorubicin—prostate cancer	0.00518	0.0116	CbGbCtD
Phenobarbital—CYP2C9—Nilutamide—prostate cancer	0.00516	0.0116	CbGbCtD
Phenobarbital—CYP2C9—Bicalutamide—prostate cancer	0.00516	0.0116	CbGbCtD
Phenobarbital—CYP2C19—Flutamide—prostate cancer	0.00514	0.0116	CbGbCtD
Phenobarbital—CYP1A2—Flutamide—prostate cancer	0.00474	0.0107	CbGbCtD
Phenobarbital—CYP3A5—Cabazitaxel—prostate cancer	0.00471	0.0106	CbGbCtD
Phenobarbital—ABCC1—Etoposide—prostate cancer	0.00466	0.0105	CbGbCtD
Phenobarbital—ABCB1—Estramustine—prostate cancer	0.00465	0.0105	CbGbCtD
Phenobarbital—CYP3A5—Estrone—prostate cancer	0.00461	0.0104	CbGbCtD
Phenobarbital—CYP2C8—Cabazitaxel—prostate cancer	0.00453	0.0102	CbGbCtD
Phenobarbital—ABCB11—Doxorubicin—prostate cancer	0.00447	0.0101	CbGbCtD
Phenobarbital—CYP1B1—Doxorubicin—prostate cancer	0.00447	0.0101	CbGbCtD
Phenobarbital—CYP1A1—Estradiol—prostate cancer	0.00441	0.00992	CbGbCtD
Phenobarbital—ABCC1—Docetaxel—prostate cancer	0.00426	0.00959	CbGbCtD
Phenobarbital—CYP2C8—Ethinyl Estradiol—prostate cancer	0.00395	0.00888	CbGbCtD
Phenobarbital—CYP3A7—Estradiol—prostate cancer	0.00353	0.00794	CbGbCtD
Phenobarbital—CYP3A7-CYP3A51P—Estradiol—prostate cancer	0.00353	0.00794	CbGbCtD
Phenobarbital—CYP2E1—Mitoxantrone—prostate cancer	0.00352	0.00793	CbGbCtD
Phenobarbital—ABCC2—Etoposide—prostate cancer	0.00345	0.00776	CbGbCtD
Phenobarbital—CYP1A2—Estrone—prostate cancer	0.00343	0.00772	CbGbCtD
Phenobarbital—ABCC1—Doxorubicin—prostate cancer	0.00318	0.00715	CbGbCtD
Phenobarbital—ABCC2—Docetaxel—prostate cancer	0.00316	0.0071	CbGbCtD
Phenobarbital—CYP2C9—Estrone—prostate cancer	0.00309	0.00695	CbGbCtD
Phenobarbital—ABCB1—Cabazitaxel—prostate cancer	0.00307	0.0069	CbGbCtD
Phenobarbital—CYP3A4—Bicalutamide—prostate cancer	0.003	0.00675	CbGbCtD
Phenobarbital—ABCB1—Estrone—prostate cancer	0.003	0.00675	CbGbCtD
Phenobarbital—CYP3A4—Estramustine—prostate cancer	0.00279	0.00627	CbGbCtD
Phenobarbital—ABCB1—Ethinyl Estradiol—prostate cancer	0.00267	0.00601	CbGbCtD
Phenobarbital—CYP3A5—Estradiol—prostate cancer	0.00265	0.00595	CbGbCtD
Phenobarbital—CYP2C8—Estradiol—prostate cancer	0.00254	0.00572	CbGbCtD
Phenobarbital—CYP3A4—Abiraterone—prostate cancer	0.00248	0.00559	CbGbCtD
Phenobarbital—CYP3A4—Flutamide—prostate cancer	0.00248	0.00559	CbGbCtD
Phenobarbital—ABCC2—Doxorubicin—prostate cancer	0.00235	0.00529	CbGbCtD
Phenobarbital—CYP2C9—Capecitabine—prostate cancer	0.00234	0.00527	CbGbCtD
Phenobarbital—CYP1A2—Conjugated Estrogens—prostate cancer	0.00224	0.00505	CbGbCtD
Phenobarbital—CYP2E1—Etoposide—prostate cancer	0.00222	0.005	CbGbCtD
Phenobarbital—CYP2C19—Estradiol—prostate cancer	0.00213	0.0048	CbGbCtD
Phenobarbital—CYP3A7—Docetaxel—prostate cancer	0.00211	0.00474	CbGbCtD
Phenobarbital—CYP3A7-CYP3A51P—Docetaxel—prostate cancer	0.00211	0.00474	CbGbCtD
Phenobarbital—CYP1A2—Estradiol—prostate cancer	0.00197	0.00443	CbGbCtD
Phenobarbital—ABCB1—Conjugated Estrogens—prostate cancer	0.00196	0.00441	CbGbCtD
Phenobarbital—CYP3A4—Cabazitaxel—prostate cancer	0.00184	0.00414	CbGbCtD
Phenobarbital—CYP2C19—Prednisone—prostate cancer	0.00183	0.00413	CbGbCtD
Phenobarbital—CYP3A4—Estrone—prostate cancer	0.0018	0.00404	CbGbCtD
Phenobarbital—ABCB1—Mitoxantrone—prostate cancer	0.00178	0.00401	CbGbCtD
Phenobarbital—CYP2C9—Estradiol—prostate cancer	0.00177	0.00399	CbGbCtD
Phenobarbital—CYP3A5—Etoposide—prostate cancer	0.00173	0.00389	CbGbCtD
Phenobarbital—ABCB1—Estradiol—prostate cancer	0.00172	0.00387	CbGbCtD
Phenobarbital—CYP2C8—Etoposide—prostate cancer	0.00166	0.00374	CbGbCtD
Phenobarbital—CYP3A4—Ethinyl Estradiol—prostate cancer	0.0016	0.0036	CbGbCtD
Phenobarbital—CYP3A5—Docetaxel—prostate cancer	0.00158	0.00356	CbGbCtD
Phenobarbital—CYP2B6—Doxorubicin—prostate cancer	0.0015	0.00337	CbGbCtD
Phenobarbital—ABCB1—Prednisone—prostate cancer	0.00148	0.00333	CbGbCtD
Phenobarbital—CYP4B1—prostate gland—prostate cancer	0.00135	0.0521	CbGeAlD
Phenobarbital—CYP1A2—Etoposide—prostate cancer	0.00129	0.00289	CbGbCtD
Phenobarbital—CYP2C19—urine—prostate cancer	0.00119	0.0458	CbGeAlD
Phenobarbital—CYP3A4—Conjugated Estrogens—prostate cancer	0.00117	0.00264	CbGbCtD
Phenobarbital—ABCB1—Etoposide—prostate cancer	0.00112	0.00253	CbGbCtD
Phenobarbital—CYP3A4—Mitoxantrone—prostate cancer	0.00107	0.0024	CbGbCtD
Phenobarbital—CYP3A4—Estradiol—prostate cancer	0.00103	0.00232	CbGbCtD
Phenobarbital—CYP4A11—renal system—prostate cancer	0.00103	0.0398	CbGeAlD
Phenobarbital—ABCB1—Docetaxel—prostate cancer	0.00103	0.00231	CbGbCtD
Phenobarbital—CYP1A2—urine—prostate cancer	0.000968	0.0374	CbGeAlD
Phenobarbital—CYP2C9—urine—prostate cancer	0.000919	0.0355	CbGeAlD
Phenobarbital—CYP4B1—urethra—prostate cancer	0.000903	0.0349	CbGeAlD
Phenobarbital—CYP3A4—Prednisone—prostate cancer	0.000887	0.002	CbGbCtD
Phenobarbital—CYP2E1—urine—prostate cancer	0.000871	0.0337	CbGeAlD
Phenobarbital—SLCO2A1—prostate gland—prostate cancer	0.000807	0.0312	CbGeAlD
Phenobarbital—ABCB1—Doxorubicin—prostate cancer	0.000767	0.00173	CbGbCtD
Phenobarbital—CYP3A4—urine—prostate cancer	0.000701	0.0271	CbGeAlD
Phenobarbital—SLCO2A1—seminal vesicle—prostate cancer	0.000683	0.0264	CbGeAlD
Phenobarbital—CYP3A4—Etoposide—prostate cancer	0.000674	0.00152	CbGbCtD
Phenobarbital—CYP2A6—prostate gland—prostate cancer	0.000662	0.0256	CbGeAlD
Phenobarbital—ABCC3—prostate gland—prostate cancer	0.00062	0.024	CbGeAlD
Phenobarbital—CYP3A4—Docetaxel—prostate cancer	0.000616	0.00139	CbGbCtD
Phenobarbital—CYP4B1—testis—prostate cancer	0.000594	0.023	CbGeAlD
Phenobarbital—SLCO2A1—epithelium—prostate cancer	0.000593	0.0229	CbGeAlD
Phenobarbital—CYP2A6—seminal vesicle—prostate cancer	0.00056	0.0216	CbGeAlD
Phenobarbital—SLCO2A1—renal system—prostate cancer	0.00055	0.0213	CbGeAlD
Phenobarbital—SLCO2A1—urethra—prostate cancer	0.00054	0.0209	CbGeAlD
Phenobarbital—ABCC2—prostate gland—prostate cancer	0.000495	0.0191	CbGeAlD
Phenobarbital—CYP1B1—prostate gland—prostate cancer	0.000485	0.0187	CbGeAlD
Phenobarbital—CYP3A4—Doxorubicin—prostate cancer	0.000459	0.00103	CbGbCtD
Phenobarbital—CHRNA7—renal system—prostate cancer	0.000451	0.0174	CbGeAlD
Phenobarbital—ABCC1—prostate gland—prostate cancer	0.000436	0.0169	CbGeAlD
Phenobarbital—CYP4B1—lymph node—prostate cancer	0.000431	0.0166	CbGeAlD
Phenobarbital—ABCB11—testis—prostate cancer	0.000429	0.0166	CbGeAlD
Phenobarbital—ABCC3—renal system—prostate cancer	0.000423	0.0163	CbGeAlD
Phenobarbital—GRIA2—testis—prostate cancer	0.000396	0.0153	CbGeAlD
Phenobarbital—ABCC1—seminal vesicle—prostate cancer	0.000369	0.0143	CbGeAlD
Phenobarbital—CHRFAM7A—testis—prostate cancer	0.000361	0.014	CbGeAlD
Phenobarbital—SLCO2A1—testis—prostate cancer	0.000356	0.0137	CbGeAlD
Phenobarbital—ABCC2—renal system—prostate cancer	0.000338	0.013	CbGeAlD
Phenobarbital—CYP3A5—prostate gland—prostate cancer	0.000335	0.013	CbGeAlD
Phenobarbital—CYP1B1—renal system—prostate cancer	0.000331	0.0128	CbGeAlD
Phenobarbital—CYP2E1—prostate gland—prostate cancer	0.000313	0.0121	CbGeAlD
Phenobarbital—ABCC1—urethra—prostate cancer	0.000292	0.0113	CbGeAlD
Phenobarbital—CHRNA7—testis—prostate cancer	0.000292	0.0113	CbGeAlD
Phenobarbital—ABCC3—testis—prostate cancer	0.000273	0.0106	CbGeAlD
Phenobarbital—CYP2E1—seminal vesicle—prostate cancer	0.000265	0.0102	CbGeAlD
Phenobarbital—SLCO2A1—lymph node—prostate cancer	0.000258	0.00996	CbGeAlD
Phenobarbital—CYP2C8—renal system—prostate cancer	0.000253	0.00978	CbGeAlD
Phenobarbital—CYP1A1—epithelium—prostate cancer	0.000252	0.00974	CbGeAlD
Phenobarbital—CYP1A2—renal system—prostate cancer	0.000237	0.00915	CbGeAlD
Phenobarbital—CYP1A1—renal system—prostate cancer	0.000234	0.00903	CbGeAlD
Phenobarbital—CYP1A1—urethra—prostate cancer	0.00023	0.00887	CbGeAlD
Phenobarbital—CYP3A5—renal system—prostate cancer	0.000229	0.00883	CbGeAlD
Phenobarbital—CYP2B6—renal system—prostate cancer	0.000227	0.00878	CbGeAlD
Phenobarbital—ABCC2—testis—prostate cancer	0.000218	0.00843	CbGeAlD
Phenobarbital—CYP1B1—testis—prostate cancer	0.000214	0.00826	CbGeAlD
Phenobarbital—CYP2E1—renal system—prostate cancer	0.000213	0.00823	CbGeAlD
Phenobarbital—CYP2E1—urethra—prostate cancer	0.000209	0.00809	CbGeAlD
Phenobarbital—ABCC3—lymph node—prostate cancer	0.000198	0.00765	CbGeAlD
Phenobarbital—ABCC1—testis—prostate cancer	0.000192	0.00743	CbGeAlD
Phenobarbital—ABCB1—prostate gland—prostate cancer	0.000178	0.00688	CbGeAlD
Phenobarbital—CYP3A4—renal system—prostate cancer	0.000172	0.00663	CbGeAlD
Phenobarbital—CYP2C8—testis—prostate cancer	0.000164	0.00632	CbGeAlD
Phenobarbital—ABCC2—lymph node—prostate cancer	0.000158	0.00611	CbGeAlD
Phenobarbital—CYP1B1—lymph node—prostate cancer	0.000155	0.00598	CbGeAlD
Phenobarbital—Methsuximide—CYP2C19—prostate cancer	0.000151	0.119	CrCbGaD
Phenobarbital—ABCB1—seminal vesicle—prostate cancer	0.000151	0.00582	CbGeAlD
Phenobarbital—Phenytoin—CYP2C18—prostate cancer	0.000147	0.116	CrCbGaD
Phenobarbital—CYP2B6—testis—prostate cancer	0.000147	0.00567	CbGeAlD
Phenobarbital—Amobarbital—CYP2A6—prostate cancer	0.000143	0.113	CrCbGaD
Phenobarbital—ABCC1—lymph node—prostate cancer	0.000139	0.00538	CbGeAlD
Phenobarbital—CYP2E1—testis—prostate cancer	0.000138	0.00532	CbGeAlD
Phenobarbital—ABCB1—epithelium—prostate cancer	0.000131	0.00506	CbGeAlD
Phenobarbital—ABCB1—renal system—prostate cancer	0.000121	0.00469	CbGeAlD
Phenobarbital—Pentobarbital—CYP2A6—prostate cancer	0.00012	0.0946	CrCbGaD
Phenobarbital—ABCB1—urethra—prostate cancer	0.000119	0.00461	CbGeAlD
Phenobarbital—CYP1A1—lymph node—prostate cancer	0.00011	0.00423	CbGeAlD
Phenobarbital—Ethotoin—CYP2C19—prostate cancer	0.000108	0.0851	CrCbGaD
Phenobarbital—Primidone—CYP2C19—prostate cancer	0.0001	0.0789	CrCbGaD
Phenobarbital—Phenytoin—CYP3A5—prostate cancer	9.7e-05	0.0763	CrCbGaD
Phenobarbital—Methylphenobarbital—CYP2C19—prostate cancer	9.41e-05	0.074	CrCbGaD
Phenobarbital—ABCB1—bone marrow—prostate cancer	9.18e-05	0.00355	CbGeAlD
Phenobarbital—Pain—Goserelin—prostate cancer	9.16e-05	0.00123	CcSEcCtD
Phenobarbital—Constipation—Goserelin—prostate cancer	9.16e-05	0.00123	CcSEcCtD
Phenobarbital—Nausea—Bicalutamide—prostate cancer	9.14e-05	0.00123	CcSEcCtD
Phenobarbital—Loss of consciousness—Estradiol—prostate cancer	9.14e-05	0.00122	CcSEcCtD
Phenobarbital—Mood swings—Prednisone—prostate cancer	9.09e-05	0.00122	CcSEcCtD
Phenobarbital—Constipation—Conjugated Estrogens—prostate cancer	9.07e-05	0.00122	CcSEcCtD
Phenobarbital—Pain—Conjugated Estrogens—prostate cancer	9.07e-05	0.00122	CcSEcCtD
Phenobarbital—Mental disability—Epirubicin—prostate cancer	8.97e-05	0.0012	CcSEcCtD
Phenobarbital—Arthralgia—Estradiol—prostate cancer	8.86e-05	0.00119	CcSEcCtD
Phenobarbital—Myalgia—Estradiol—prostate cancer	8.86e-05	0.00119	CcSEcCtD
Phenobarbital—Anxiety—Estradiol—prostate cancer	8.83e-05	0.00118	CcSEcCtD
Phenobarbital—Feeling abnormal—Goserelin—prostate cancer	8.83e-05	0.00118	CcSEcCtD
Phenobarbital—Erythema multiforme—Etoposide—prostate cancer	8.76e-05	0.00117	CcSEcCtD
Phenobarbital—Coma—Doxorubicin—prostate cancer	8.74e-05	0.00117	CcSEcCtD
Phenobarbital—Dizziness—Ethinyl Estradiol—prostate cancer	8.61e-05	0.00115	CcSEcCtD
Phenobarbital—Confusional state—Estradiol—prostate cancer	8.56e-05	0.00115	CcSEcCtD
Phenobarbital—Urticaria—Goserelin—prostate cancer	8.51e-05	0.00114	CcSEcCtD
Phenobarbital—Stevens-Johnson syndrome—Docetaxel—prostate cancer	8.5e-05	0.00114	CcSEcCtD
Phenobarbital—Body temperature increased—Goserelin—prostate cancer	8.47e-05	0.00113	CcSEcCtD
Phenobarbital—Pentobarbital—CYP2C19—prostate cancer	8.45e-05	0.0665	CrCbGaD
Phenobarbital—Renal failure—Docetaxel—prostate cancer	8.43e-05	0.00113	CcSEcCtD
Phenobarbital—Urticaria—Conjugated Estrogens—prostate cancer	8.43e-05	0.00113	CcSEcCtD
Phenobarbital—Body temperature increased—Conjugated Estrogens—prostate cancer	8.39e-05	0.00112	CcSEcCtD
Phenobarbital—Shock—Estradiol—prostate cancer	8.35e-05	0.00112	CcSEcCtD
Phenobarbital—Mental disability—Doxorubicin—prostate cancer	8.3e-05	0.00111	CcSEcCtD
Phenobarbital—Vomiting—Ethinyl Estradiol—prostate cancer	8.27e-05	0.00111	CcSEcCtD
Phenobarbital—Myalgia—Mitoxantrone—prostate cancer	8.25e-05	0.00111	CcSEcCtD
Phenobarbital—Arthralgia—Mitoxantrone—prostate cancer	8.25e-05	0.00111	CcSEcCtD
Phenobarbital—Stevens-Johnson syndrome—Capecitabine—prostate cancer	8.23e-05	0.0011	CcSEcCtD
Phenobarbital—Anxiety—Mitoxantrone—prostate cancer	8.22e-05	0.0011	CcSEcCtD
Phenobarbital—Rash—Ethinyl Estradiol—prostate cancer	8.21e-05	0.0011	CcSEcCtD
Phenobarbital—Dermatitis—Ethinyl Estradiol—prostate cancer	8.2e-05	0.0011	CcSEcCtD
Phenobarbital—Renal failure—Capecitabine—prostate cancer	8.16e-05	0.00109	CcSEcCtD
Phenobarbital—Headache—Ethinyl Estradiol—prostate cancer	8.15e-05	0.00109	CcSEcCtD
Phenobarbital—Confusional state—Mitoxantrone—prostate cancer	7.98e-05	0.00107	CcSEcCtD
Phenobarbital—Dermatitis exfoliative—Epirubicin—prostate cancer	7.95e-05	0.00107	CcSEcCtD
Phenobarbital—Hypersensitivity—Goserelin—prostate cancer	7.89e-05	0.00106	CcSEcCtD
Phenobarbital—Dermatitis bullous—Epirubicin—prostate cancer	7.85e-05	0.00105	CcSEcCtD
Phenobarbital—ABCB1—testis—prostate cancer	7.85e-05	0.00303	CbGeAlD
Phenobarbital—Hypersensitivity—Conjugated Estrogens—prostate cancer	7.82e-05	0.00105	CcSEcCtD
Phenobarbital—Shock—Mitoxantrone—prostate cancer	7.78e-05	0.00104	CcSEcCtD
Phenobarbital—Musculoskeletal discomfort—Estradiol—prostate cancer	7.74e-05	0.00104	CcSEcCtD
Phenobarbital—Nausea—Ethinyl Estradiol—prostate cancer	7.73e-05	0.00104	CcSEcCtD
Phenobarbital—Hepatitis—Docetaxel—prostate cancer	7.7e-05	0.00103	CcSEcCtD
Phenobarbital—Lethargy—Epirubicin—prostate cancer	7.66e-05	0.00103	CcSEcCtD
Phenobarbital—Bradycardia—Capecitabine—prostate cancer	7.59e-05	0.00102	CcSEcCtD
Phenobarbital—Somnolence—Estradiol—prostate cancer	7.55e-05	0.00101	CcSEcCtD
Phenobarbital—Hepatitis—Capecitabine—prostate cancer	7.45e-05	0.000998	CcSEcCtD
Phenobarbital—Hypotension—Mitoxantrone—prostate cancer	7.39e-05	0.00099	CcSEcCtD
Phenobarbital—Affect lability—Epirubicin—prostate cancer	7.39e-05	0.00099	CcSEcCtD
Phenobarbital—Dermatitis exfoliative—Doxorubicin—prostate cancer	7.36e-05	0.000986	CcSEcCtD
Phenobarbital—Erythema multiforme—Docetaxel—prostate cancer	7.28e-05	0.000975	CcSEcCtD
Phenobarbital—Dermatitis bullous—Doxorubicin—prostate cancer	7.27e-05	0.000973	CcSEcCtD
Phenobarbital—Pain—Estradiol—prostate cancer	7.26e-05	0.000973	CcSEcCtD
Phenobarbital—Constipation—Estradiol—prostate cancer	7.26e-05	0.000973	CcSEcCtD
Phenobarbital—Vertigo—Etoposide—prostate cancer	7.24e-05	0.00097	CcSEcCtD
Phenobarbital—Musculoskeletal discomfort—Mitoxantrone—prostate cancer	7.21e-05	0.000966	CcSEcCtD
Phenobarbital—Mood swings—Epirubicin—prostate cancer	7.11e-05	0.000952	CcSEcCtD
Phenobarbital—Loss of consciousness—Etoposide—prostate cancer	7.09e-05	0.000949	CcSEcCtD
Phenobarbital—Lethargy—Doxorubicin—prostate cancer	7.09e-05	0.000949	CcSEcCtD
Phenobarbital—Dizziness—Goserelin—prostate cancer	7.08e-05	0.000949	CcSEcCtD
Phenobarbital—Ataxia—Epirubicin—prostate cancer	7.06e-05	0.000945	CcSEcCtD
Phenobarbital—Erythema multiforme—Capecitabine—prostate cancer	7.05e-05	0.000944	CcSEcCtD
Phenobarbital—Somnolence—Mitoxantrone—prostate cancer	7.03e-05	0.000942	CcSEcCtD
Phenobarbital—Dizziness—Conjugated Estrogens—prostate cancer	7.02e-05	0.00094	CcSEcCtD
Phenobarbital—Feeling abnormal—Estradiol—prostate cancer	7e-05	0.000937	CcSEcCtD
Phenobarbital—Affect lability—Doxorubicin—prostate cancer	6.83e-05	0.000916	CcSEcCtD
Phenobarbital—Vomiting—Goserelin—prostate cancer	6.81e-05	0.000912	CcSEcCtD
Phenobarbital—Constipation—Mitoxantrone—prostate cancer	6.76e-05	0.000906	CcSEcCtD
Phenobarbital—Pain—Mitoxantrone—prostate cancer	6.76e-05	0.000906	CcSEcCtD
Phenobarbital—Toxic epidermal necrolysis—Epirubicin—prostate cancer	6.76e-05	0.000905	CcSEcCtD
Phenobarbital—Bradycardia—Prednisone—prostate cancer	6.76e-05	0.000905	CcSEcCtD
Phenobarbital—Rash—Goserelin—prostate cancer	6.75e-05	0.000905	CcSEcCtD
Phenobarbital—Dermatitis—Goserelin—prostate cancer	6.75e-05	0.000904	CcSEcCtD
Phenobarbital—Vomiting—Conjugated Estrogens—prostate cancer	6.74e-05	0.000904	CcSEcCtD
Phenobarbital—Urticaria—Estradiol—prostate cancer	6.74e-05	0.000904	CcSEcCtD
Phenobarbital—Body temperature increased—Estradiol—prostate cancer	6.71e-05	0.000899	CcSEcCtD
Phenobarbital—Headache—Goserelin—prostate cancer	6.71e-05	0.000899	CcSEcCtD
Phenobarbital—Erythema—Docetaxel—prostate cancer	6.7e-05	0.000898	CcSEcCtD
Phenobarbital—Rash—Conjugated Estrogens—prostate cancer	6.69e-05	0.000896	CcSEcCtD
Phenobarbital—Dermatitis—Conjugated Estrogens—prostate cancer	6.68e-05	0.000895	CcSEcCtD
Phenobarbital—Headache—Conjugated Estrogens—prostate cancer	6.65e-05	0.00089	CcSEcCtD
Phenobarbital—Confusional state—Etoposide—prostate cancer	6.63e-05	0.000889	CcSEcCtD
Phenobarbital—Hallucination—Prednisone—prostate cancer	6.6e-05	0.000885	CcSEcCtD
Phenobarbital—Phenytoin—CYP2C19—prostate cancer	6.6e-05	0.052	CrCbGaD
Phenobarbital—Mood swings—Doxorubicin—prostate cancer	6.58e-05	0.000881	CcSEcCtD
Phenobarbital—Ataxia—Doxorubicin—prostate cancer	6.53e-05	0.000875	CcSEcCtD
Phenobarbital—Feeling abnormal—Mitoxantrone—prostate cancer	6.52e-05	0.000873	CcSEcCtD
Phenobarbital—Erythema—Capecitabine—prostate cancer	6.49e-05	0.000869	CcSEcCtD
Phenobarbital—Asthma—Epirubicin—prostate cancer	6.49e-05	0.000869	CcSEcCtD
Phenobarbital—Primidone—CYP3A4—prostate cancer	6.38e-05	0.0502	CrCbGaD
Phenobarbital—Nausea—Goserelin—prostate cancer	6.36e-05	0.000852	CcSEcCtD
Phenobarbital—Nausea—Conjugated Estrogens—prostate cancer	6.3e-05	0.000844	CcSEcCtD
Phenobarbital—Urticaria—Mitoxantrone—prostate cancer	6.28e-05	0.000842	CcSEcCtD
Phenobarbital—Hypersensitivity—Estradiol—prostate cancer	6.26e-05	0.000838	CcSEcCtD
Phenobarbital—Body temperature increased—Mitoxantrone—prostate cancer	6.25e-05	0.000838	CcSEcCtD
Phenobarbital—Toxic epidermal necrolysis—Doxorubicin—prostate cancer	6.25e-05	0.000838	CcSEcCtD
Phenobarbital—Hypotension—Etoposide—prostate cancer	6.15e-05	0.000824	CcSEcCtD
Phenobarbital—Syncope—Docetaxel—prostate cancer	6.01e-05	0.000805	CcSEcCtD
Phenobarbital—Asthma—Doxorubicin—prostate cancer	6e-05	0.000804	CcSEcCtD
Phenobarbital—Loss of consciousness—Docetaxel—prostate cancer	5.89e-05	0.000789	CcSEcCtD
Phenobarbital—Somnolence—Etoposide—prostate cancer	5.85e-05	0.000784	CcSEcCtD
Phenobarbital—Vertigo—Capecitabine—prostate cancer	5.83e-05	0.000781	CcSEcCtD
Phenobarbital—Hypersensitivity—Mitoxantrone—prostate cancer	5.83e-05	0.000781	CcSEcCtD
Phenobarbital—Syncope—Capecitabine—prostate cancer	5.82e-05	0.000779	CcSEcCtD
Phenobarbital—Drowsiness—Epirubicin—prostate cancer	5.78e-05	0.000775	CcSEcCtD
Phenobarbital—Erythema—Prednisone—prostate cancer	5.78e-05	0.000774	CcSEcCtD
Phenobarbital—Stevens-Johnson syndrome—Epirubicin—prostate cancer	5.73e-05	0.000768	CcSEcCtD
Phenobarbital—Arthralgia—Docetaxel—prostate cancer	5.7e-05	0.000764	CcSEcCtD
Phenobarbital—Myalgia—Docetaxel—prostate cancer	5.7e-05	0.000764	CcSEcCtD
Phenobarbital—Loss of consciousness—Capecitabine—prostate cancer	5.7e-05	0.000764	CcSEcCtD
Phenobarbital—ABCB1—lymph node—prostate cancer	5.69e-05	0.0022	CbGeAlD
Phenobarbital—Renal failure—Epirubicin—prostate cancer	5.69e-05	0.000762	CcSEcCtD
Phenobarbital—Pain—Etoposide—prostate cancer	5.63e-05	0.000754	CcSEcCtD
Phenobarbital—Constipation—Etoposide—prostate cancer	5.63e-05	0.000754	CcSEcCtD
Phenobarbital—Dizziness—Estradiol—prostate cancer	5.61e-05	0.000752	CcSEcCtD
Phenobarbital—Arthralgia—Capecitabine—prostate cancer	5.52e-05	0.00074	CcSEcCtD
Phenobarbital—Myalgia—Capecitabine—prostate cancer	5.52e-05	0.00074	CcSEcCtD
Phenobarbital—Confusional state—Docetaxel—prostate cancer	5.51e-05	0.000739	CcSEcCtD
Phenobarbital—Anxiety—Capecitabine—prostate cancer	5.5e-05	0.000737	CcSEcCtD
Phenobarbital—Feeling abnormal—Etoposide—prostate cancer	5.42e-05	0.000726	CcSEcCtD
Phenobarbital—Vomiting—Estradiol—prostate cancer	5.4e-05	0.000723	CcSEcCtD
Phenobarbital—Shock—Docetaxel—prostate cancer	5.38e-05	0.000721	CcSEcCtD
Phenobarbital—Pentobarbital—CYP3A4—prostate cancer	5.38e-05	0.0423	CrCbGaD
Phenobarbital—Rash—Estradiol—prostate cancer	5.35e-05	0.000717	CcSEcCtD
Phenobarbital—Drowsiness—Doxorubicin—prostate cancer	5.35e-05	0.000717	CcSEcCtD
Phenobarbital—Dermatitis—Estradiol—prostate cancer	5.35e-05	0.000717	CcSEcCtD
Phenobarbital—Confusional state—Capecitabine—prostate cancer	5.34e-05	0.000715	CcSEcCtD
Phenobarbital—Headache—Estradiol—prostate cancer	5.32e-05	0.000713	CcSEcCtD
Phenobarbital—Agitation—Prednisone—prostate cancer	5.31e-05	0.000711	CcSEcCtD
Phenobarbital—Stevens-Johnson syndrome—Doxorubicin—prostate cancer	5.31e-05	0.000711	CcSEcCtD
Phenobarbital—Bradycardia—Epirubicin—prostate cancer	5.29e-05	0.000708	CcSEcCtD
Phenobarbital—Angioedema—Prednisone—prostate cancer	5.28e-05	0.000707	CcSEcCtD
Phenobarbital—Renal failure—Doxorubicin—prostate cancer	5.26e-05	0.000705	CcSEcCtD
Phenobarbital—Urticaria—Etoposide—prostate cancer	5.23e-05	0.0007	CcSEcCtD
Phenobarbital—Shock—Capecitabine—prostate cancer	5.21e-05	0.000698	CcSEcCtD
Phenobarbital—Body temperature increased—Etoposide—prostate cancer	5.2e-05	0.000697	CcSEcCtD
Phenobarbital—Vertigo—Prednisone—prostate cancer	5.19e-05	0.000696	CcSEcCtD
Phenobarbital—Hepatitis—Epirubicin—prostate cancer	5.19e-05	0.000696	CcSEcCtD
Phenobarbital—Syncope—Prednisone—prostate cancer	5.18e-05	0.000694	CcSEcCtD
Phenobarbital—Hypotension—Docetaxel—prostate cancer	5.11e-05	0.000685	CcSEcCtD
Phenobarbital—Loss of consciousness—Prednisone—prostate cancer	5.08e-05	0.00068	CcSEcCtD
Phenobarbital—Nausea—Estradiol—prostate cancer	5.04e-05	0.000676	CcSEcCtD
Phenobarbital—Vomiting—Mitoxantrone—prostate cancer	5.03e-05	0.000674	CcSEcCtD
Phenobarbital—Rash—Mitoxantrone—prostate cancer	4.99e-05	0.000668	CcSEcCtD
Phenobarbital—Dermatitis—Mitoxantrone—prostate cancer	4.98e-05	0.000668	CcSEcCtD
Phenobarbital—Musculoskeletal discomfort—Docetaxel—prostate cancer	4.98e-05	0.000668	CcSEcCtD
Phenobarbital—Headache—Mitoxantrone—prostate cancer	4.96e-05	0.000664	CcSEcCtD
Phenobarbital—Hypotension—Capecitabine—prostate cancer	4.95e-05	0.000663	CcSEcCtD
Phenobarbital—Myalgia—Prednisone—prostate cancer	4.92e-05	0.000659	CcSEcCtD
Phenobarbital—Arthralgia—Prednisone—prostate cancer	4.92e-05	0.000659	CcSEcCtD
Phenobarbital—Erythema multiforme—Epirubicin—prostate cancer	4.91e-05	0.000658	CcSEcCtD
Phenobarbital—Anxiety—Prednisone—prostate cancer	4.9e-05	0.000657	CcSEcCtD
Phenobarbital—Bradycardia—Doxorubicin—prostate cancer	4.89e-05	0.000655	CcSEcCtD
Phenobarbital—Somnolence—Docetaxel—prostate cancer	4.86e-05	0.000651	CcSEcCtD
Phenobarbital—Hypersensitivity—Etoposide—prostate cancer	4.85e-05	0.00065	CcSEcCtD
Phenobarbital—Musculoskeletal discomfort—Capecitabine—prostate cancer	4.82e-05	0.000646	CcSEcCtD
Phenobarbital—Hepatitis—Doxorubicin—prostate cancer	4.8e-05	0.000644	CcSEcCtD
Phenobarbital—Nausea—Mitoxantrone—prostate cancer	4.7e-05	0.00063	CcSEcCtD
Phenobarbital—Constipation—Docetaxel—prostate cancer	4.68e-05	0.000627	CcSEcCtD
Phenobarbital—Pain—Docetaxel—prostate cancer	4.68e-05	0.000627	CcSEcCtD
Phenobarbital—Shock—Prednisone—prostate cancer	4.64e-05	0.000622	CcSEcCtD
Phenobarbital—Erythema multiforme—Doxorubicin—prostate cancer	4.54e-05	0.000609	CcSEcCtD
Phenobarbital—Constipation—Capecitabine—prostate cancer	4.53e-05	0.000607	CcSEcCtD
Phenobarbital—Pain—Capecitabine—prostate cancer	4.53e-05	0.000607	CcSEcCtD
Phenobarbital—Erythema—Epirubicin—prostate cancer	4.52e-05	0.000606	CcSEcCtD
Phenobarbital—Feeling abnormal—Docetaxel—prostate cancer	4.51e-05	0.000604	CcSEcCtD
Phenobarbital—Tension—Epirubicin—prostate cancer	4.44e-05	0.000594	CcSEcCtD
Phenobarbital—Nervousness—Epirubicin—prostate cancer	4.39e-05	0.000588	CcSEcCtD
Phenobarbital—Feeling abnormal—Capecitabine—prostate cancer	4.36e-05	0.000585	CcSEcCtD
Phenobarbital—Dizziness—Etoposide—prostate cancer	4.35e-05	0.000583	CcSEcCtD
Phenobarbital—Body temperature increased—Docetaxel—prostate cancer	4.32e-05	0.000579	CcSEcCtD
Phenobarbital—Musculoskeletal discomfort—Prednisone—prostate cancer	4.3e-05	0.000576	CcSEcCtD
Phenobarbital—Urticaria—Capecitabine—prostate cancer	4.21e-05	0.000564	CcSEcCtD
Phenobarbital—Phenytoin—CYP3A4—prostate cancer	4.2e-05	0.033	CrCbGaD
Phenobarbital—Body temperature increased—Capecitabine—prostate cancer	4.19e-05	0.000561	CcSEcCtD
Phenobarbital—Vomiting—Etoposide—prostate cancer	4.18e-05	0.000561	CcSEcCtD
Phenobarbital—Erythema—Doxorubicin—prostate cancer	4.18e-05	0.00056	CcSEcCtD
Phenobarbital—Agitation—Epirubicin—prostate cancer	4.15e-05	0.000556	CcSEcCtD
Phenobarbital—Rash—Etoposide—prostate cancer	4.15e-05	0.000556	CcSEcCtD
Phenobarbital—Dermatitis—Etoposide—prostate cancer	4.15e-05	0.000555	CcSEcCtD
Phenobarbital—Headache—Etoposide—prostate cancer	4.12e-05	0.000552	CcSEcCtD
Phenobarbital—Tension—Doxorubicin—prostate cancer	4.1e-05	0.00055	CcSEcCtD
Phenobarbital—Nervousness—Doxorubicin—prostate cancer	4.06e-05	0.000544	CcSEcCtD
Phenobarbital—Vertigo—Epirubicin—prostate cancer	4.06e-05	0.000544	CcSEcCtD
Phenobarbital—Syncope—Epirubicin—prostate cancer	4.05e-05	0.000543	CcSEcCtD
Phenobarbital—Constipation—Prednisone—prostate cancer	4.03e-05	0.00054	CcSEcCtD
Phenobarbital—Hypersensitivity—Docetaxel—prostate cancer	4.03e-05	0.00054	CcSEcCtD
Phenobarbital—Loss of consciousness—Epirubicin—prostate cancer	3.97e-05	0.000532	CcSEcCtD
Phenobarbital—Nausea—Etoposide—prostate cancer	3.91e-05	0.000524	CcSEcCtD
Phenobarbital—Hypersensitivity—Capecitabine—prostate cancer	3.9e-05	0.000523	CcSEcCtD
Phenobarbital—Feeling abnormal—Prednisone—prostate cancer	3.89e-05	0.000521	CcSEcCtD
Phenobarbital—Myalgia—Epirubicin—prostate cancer	3.85e-05	0.000516	CcSEcCtD
Phenobarbital—Arthralgia—Epirubicin—prostate cancer	3.85e-05	0.000516	CcSEcCtD
Phenobarbital—Agitation—Doxorubicin—prostate cancer	3.84e-05	0.000515	CcSEcCtD
Phenobarbital—Anxiety—Epirubicin—prostate cancer	3.83e-05	0.000514	CcSEcCtD
Phenobarbital—Vertigo—Doxorubicin—prostate cancer	3.76e-05	0.000503	CcSEcCtD
Phenobarbital—Syncope—Doxorubicin—prostate cancer	3.75e-05	0.000502	CcSEcCtD
Phenobarbital—Urticaria—Prednisone—prostate cancer	3.75e-05	0.000502	CcSEcCtD
Phenobarbital—Body temperature increased—Prednisone—prostate cancer	3.73e-05	0.000499	CcSEcCtD
Phenobarbital—Confusional state—Epirubicin—prostate cancer	3.72e-05	0.000498	CcSEcCtD
Phenobarbital—Loss of consciousness—Doxorubicin—prostate cancer	3.68e-05	0.000492	CcSEcCtD
Phenobarbital—Shock—Epirubicin—prostate cancer	3.63e-05	0.000486	CcSEcCtD
Phenobarbital—Dizziness—Docetaxel—prostate cancer	3.62e-05	0.000484	CcSEcCtD
Phenobarbital—Myalgia—Doxorubicin—prostate cancer	3.56e-05	0.000477	CcSEcCtD
Phenobarbital—Arthralgia—Doxorubicin—prostate cancer	3.56e-05	0.000477	CcSEcCtD
Phenobarbital—Anxiety—Doxorubicin—prostate cancer	3.55e-05	0.000475	CcSEcCtD
Phenobarbital—Dizziness—Capecitabine—prostate cancer	3.5e-05	0.000469	CcSEcCtD
Phenobarbital—Vomiting—Docetaxel—prostate cancer	3.48e-05	0.000466	CcSEcCtD
Phenobarbital—Hypersensitivity—Prednisone—prostate cancer	3.47e-05	0.000466	CcSEcCtD
Phenobarbital—Rash—Docetaxel—prostate cancer	3.45e-05	0.000462	CcSEcCtD
Phenobarbital—Hypotension—Epirubicin—prostate cancer	3.45e-05	0.000462	CcSEcCtD
Phenobarbital—Dermatitis—Docetaxel—prostate cancer	3.44e-05	0.000462	CcSEcCtD
Phenobarbital—Confusional state—Doxorubicin—prostate cancer	3.44e-05	0.000461	CcSEcCtD
Phenobarbital—Headache—Docetaxel—prostate cancer	3.43e-05	0.000459	CcSEcCtD
Phenobarbital—Vomiting—Capecitabine—prostate cancer	3.37e-05	0.000451	CcSEcCtD
Phenobarbital—Musculoskeletal discomfort—Epirubicin—prostate cancer	3.36e-05	0.00045	CcSEcCtD
Phenobarbital—Shock—Doxorubicin—prostate cancer	3.36e-05	0.00045	CcSEcCtD
Phenobarbital—Rash—Capecitabine—prostate cancer	3.34e-05	0.000447	CcSEcCtD
Phenobarbital—Dermatitis—Capecitabine—prostate cancer	3.34e-05	0.000447	CcSEcCtD
Phenobarbital—Headache—Capecitabine—prostate cancer	3.32e-05	0.000444	CcSEcCtD
Phenobarbital—Somnolence—Epirubicin—prostate cancer	3.28e-05	0.000439	CcSEcCtD
Phenobarbital—Nausea—Docetaxel—prostate cancer	3.25e-05	0.000435	CcSEcCtD
Phenobarbital—Hypotension—Doxorubicin—prostate cancer	3.19e-05	0.000427	CcSEcCtD
Phenobarbital—Pain—Epirubicin—prostate cancer	3.15e-05	0.000423	CcSEcCtD
Phenobarbital—Constipation—Epirubicin—prostate cancer	3.15e-05	0.000423	CcSEcCtD
Phenobarbital—Nausea—Capecitabine—prostate cancer	3.14e-05	0.000421	CcSEcCtD
Phenobarbital—Dizziness—Prednisone—prostate cancer	3.12e-05	0.000418	CcSEcCtD
Phenobarbital—Musculoskeletal discomfort—Doxorubicin—prostate cancer	3.11e-05	0.000417	CcSEcCtD
Phenobarbital—Feeling abnormal—Epirubicin—prostate cancer	3.04e-05	0.000407	CcSEcCtD
Phenobarbital—Somnolence—Doxorubicin—prostate cancer	3.03e-05	0.000406	CcSEcCtD
Phenobarbital—Vomiting—Prednisone—prostate cancer	3e-05	0.000402	CcSEcCtD
Phenobarbital—Rash—Prednisone—prostate cancer	2.97e-05	0.000398	CcSEcCtD
Phenobarbital—Dermatitis—Prednisone—prostate cancer	2.97e-05	0.000398	CcSEcCtD
Phenobarbital—Headache—Prednisone—prostate cancer	2.95e-05	0.000396	CcSEcCtD
Phenobarbital—Urticaria—Epirubicin—prostate cancer	2.93e-05	0.000393	CcSEcCtD
Phenobarbital—Constipation—Doxorubicin—prostate cancer	2.92e-05	0.000391	CcSEcCtD
Phenobarbital—Pain—Doxorubicin—prostate cancer	2.92e-05	0.000391	CcSEcCtD
Phenobarbital—Body temperature increased—Epirubicin—prostate cancer	2.92e-05	0.000391	CcSEcCtD
Phenobarbital—Feeling abnormal—Doxorubicin—prostate cancer	2.81e-05	0.000377	CcSEcCtD
Phenobarbital—Nausea—Prednisone—prostate cancer	2.8e-05	0.000375	CcSEcCtD
Phenobarbital—Hypersensitivity—Epirubicin—prostate cancer	2.72e-05	0.000364	CcSEcCtD
Phenobarbital—Urticaria—Doxorubicin—prostate cancer	2.71e-05	0.000363	CcSEcCtD
Phenobarbital—Body temperature increased—Doxorubicin—prostate cancer	2.7e-05	0.000361	CcSEcCtD
Phenobarbital—Hypersensitivity—Doxorubicin—prostate cancer	2.51e-05	0.000337	CcSEcCtD
Phenobarbital—Dizziness—Epirubicin—prostate cancer	2.44e-05	0.000327	CcSEcCtD
Phenobarbital—Vomiting—Epirubicin—prostate cancer	2.35e-05	0.000314	CcSEcCtD
Phenobarbital—Rash—Epirubicin—prostate cancer	2.33e-05	0.000312	CcSEcCtD
Phenobarbital—Dermatitis—Epirubicin—prostate cancer	2.32e-05	0.000311	CcSEcCtD
Phenobarbital—Headache—Epirubicin—prostate cancer	2.31e-05	0.00031	CcSEcCtD
Phenobarbital—Dizziness—Doxorubicin—prostate cancer	2.26e-05	0.000302	CcSEcCtD
Phenobarbital—Nausea—Epirubicin—prostate cancer	2.19e-05	0.000294	CcSEcCtD
Phenobarbital—Vomiting—Doxorubicin—prostate cancer	2.17e-05	0.000291	CcSEcCtD
Phenobarbital—Rash—Doxorubicin—prostate cancer	2.15e-05	0.000288	CcSEcCtD
Phenobarbital—Dermatitis—Doxorubicin—prostate cancer	2.15e-05	0.000288	CcSEcCtD
Phenobarbital—Headache—Doxorubicin—prostate cancer	2.14e-05	0.000286	CcSEcCtD
Phenobarbital—Nausea—Doxorubicin—prostate cancer	2.03e-05	0.000272	CcSEcCtD
Phenobarbital—CYP3A4—Metabolism—MED12—prostate cancer	7.9e-07	7.74e-06	CbGpPWpGaD
Phenobarbital—ABCB1—Metabolism—COMT—prostate cancer	7.89e-07	7.74e-06	CbGpPWpGaD
Phenobarbital—ABCB1—Metabolism—GSTP1—prostate cancer	7.85e-07	7.7e-06	CbGpPWpGaD
Phenobarbital—CYP2C8—Metabolism—CYP1A1—prostate cancer	7.85e-07	7.7e-06	CbGpPWpGaD
Phenobarbital—CYP1A1—Metabolism—PPARA—prostate cancer	7.84e-07	7.68e-06	CbGpPWpGaD
Phenobarbital—CYP3A4—Metabolism—GNG5—prostate cancer	7.83e-07	7.68e-06	CbGpPWpGaD
Phenobarbital—CYP2E1—Metabolism—CAV1—prostate cancer	7.81e-07	7.66e-06	CbGpPWpGaD
Phenobarbital—CYP3A5—Metabolism—CAV1—prostate cancer	7.8e-07	7.64e-06	CbGpPWpGaD
Phenobarbital—CYP2C8—Metabolism—ERCC2—prostate cancer	7.79e-07	7.64e-06	CbGpPWpGaD
Phenobarbital—CYP2C19—Metabolism of lipids and lipoproteins—EP300—prostate cancer	7.79e-07	7.63e-06	CbGpPWpGaD
Phenobarbital—CYP1A2—Metabolism—SLC5A5—prostate cancer	7.78e-07	7.63e-06	CbGpPWpGaD
Phenobarbital—ABCB1—Metabolism—ITPR1—prostate cancer	7.73e-07	7.58e-06	CbGpPWpGaD
Phenobarbital—CYP2C9—Metabolism—RXRA—prostate cancer	7.65e-07	7.5e-06	CbGpPWpGaD
Phenobarbital—CYP1A2—Metabolism—CYP2E1—prostate cancer	7.6e-07	7.45e-06	CbGpPWpGaD
Phenobarbital—CYP3A4—Metabolism—NCOA3—prostate cancer	7.55e-07	7.4e-06	CbGpPWpGaD
Phenobarbital—CYP3A7—Metabolism—PIK3CB—prostate cancer	7.53e-07	7.38e-06	CbGpPWpGaD
Phenobarbital—CYP1A2—Metabolism—NQO1—prostate cancer	7.52e-07	7.37e-06	CbGpPWpGaD
Phenobarbital—CYP2C19—Metabolism—TYMS—prostate cancer	7.48e-07	7.33e-06	CbGpPWpGaD
Phenobarbital—CYP2A6—Metabolism—NOS3—prostate cancer	7.48e-07	7.33e-06	CbGpPWpGaD
Phenobarbital—CYP3A7—Metabolism—PTGS2—prostate cancer	7.46e-07	7.31e-06	CbGpPWpGaD
Phenobarbital—ABCC1—Metabolism—PTEN—prostate cancer	7.46e-07	7.31e-06	CbGpPWpGaD
Phenobarbital—CYP2C9—Metabolism of lipids and lipoproteins—PTEN—prostate cancer	7.44e-07	7.3e-06	CbGpPWpGaD
Phenobarbital—CYP1A2—Metabolism—TH—prostate cancer	7.41e-07	7.26e-06	CbGpPWpGaD
Phenobarbital—ABCC1—Disease—MYC—prostate cancer	7.4e-07	7.26e-06	CbGpPWpGaD
Phenobarbital—CYP2C19—Metabolism—GSTM1—prostate cancer	7.4e-07	7.25e-06	CbGpPWpGaD
Phenobarbital—ABCC1—Disease—TGFB1—prostate cancer	7.38e-07	7.24e-06	CbGpPWpGaD
Phenobarbital—CYP2C9—Metabolism—COMT—prostate cancer	7.37e-07	7.23e-06	CbGpPWpGaD
Phenobarbital—CYP1A1—Metabolism—CAV1—prostate cancer	7.37e-07	7.22e-06	CbGpPWpGaD
Phenobarbital—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CB—prostate cancer	7.36e-07	7.22e-06	CbGpPWpGaD
Phenobarbital—CYP2C9—Metabolism—GSTP1—prostate cancer	7.34e-07	7.19e-06	CbGpPWpGaD
Phenobarbital—CYP1A2—Metabolism—CYP3A4—prostate cancer	7.33e-07	7.19e-06	CbGpPWpGaD
Phenobarbital—CYP2C8—Metabolism—MTHFR—prostate cancer	7.32e-07	7.18e-06	CbGpPWpGaD
Phenobarbital—ABCB1—Metabolism—TYMS—prostate cancer	7.3e-07	7.16e-06	CbGpPWpGaD
Phenobarbital—CYP1A2—Metabolism of lipids and lipoproteins—PTGS2—prostate cancer	7.29e-07	7.15e-06	CbGpPWpGaD
Phenobarbital—CYP2B6—Metabolism—PIK3CG—prostate cancer	7.27e-07	7.12e-06	CbGpPWpGaD
Phenobarbital—CYP2C19—Metabolism—LPL—prostate cancer	7.26e-07	7.12e-06	CbGpPWpGaD
Phenobarbital—ABCC1—Disease—EGFR—prostate cancer	7.24e-07	7.1e-06	CbGpPWpGaD
Phenobarbital—CYP2C9—Metabolism—ITPR1—prostate cancer	7.22e-07	7.08e-06	CbGpPWpGaD
Phenobarbital—ABCB1—Metabolism—GSTM1—prostate cancer	7.22e-07	7.08e-06	CbGpPWpGaD
Phenobarbital—CYP1B1—Metabolism—PTEN—prostate cancer	7.21e-07	7.07e-06	CbGpPWpGaD
Phenobarbital—CYP1A2—Metabolism—CYP1B1—prostate cancer	7.21e-07	7.07e-06	CbGpPWpGaD
Phenobarbital—CYP3A4—Metabolism—HPGDS—prostate cancer	7.2e-07	7.06e-06	CbGpPWpGaD
Phenobarbital—CYP2C8—Metabolism—PPARA—prostate cancer	7.18e-07	7.04e-06	CbGpPWpGaD
Phenobarbital—CYP3A4—Metabolism—CYP2C19—prostate cancer	7.15e-07	7.01e-06	CbGpPWpGaD
Phenobarbital—CYP2E1—Metabolism—PIK3CG—prostate cancer	7.12e-07	6.98e-06	CbGpPWpGaD
Phenobarbital—ABCC1—Metabolism—EP300—prostate cancer	7.11e-07	6.97e-06	CbGpPWpGaD
Phenobarbital—CYP3A5—Metabolism—PIK3CG—prostate cancer	7.1e-07	6.96e-06	CbGpPWpGaD
Phenobarbital—CYP2C9—Metabolism of lipids and lipoproteins—EP300—prostate cancer	7.1e-07	6.96e-06	CbGpPWpGaD
Phenobarbital—ABCB1—Metabolism—LPL—prostate cancer	7.08e-07	6.95e-06	CbGpPWpGaD
Phenobarbital—CYP1A1—Metabolism of lipids and lipoproteins—PIK3CA—prostate cancer	7.04e-07	6.9e-06	CbGpPWpGaD
Phenobarbital—CYP2C19—Metabolism—CYP1A1—prostate cancer	7.01e-07	6.87e-06	CbGpPWpGaD
Phenobarbital—ABCB11—Metabolism—PIK3CA—prostate cancer	7.01e-07	6.87e-06	CbGpPWpGaD
Phenobarbital—CYP3A4—Metabolism—GSTT1—prostate cancer	6.98e-07	6.84e-06	CbGpPWpGaD
Phenobarbital—CYP3A4—Metabolism—ACHE—prostate cancer	6.98e-07	6.84e-06	CbGpPWpGaD
Phenobarbital—CYP1A2—Metabolism—GGT1—prostate cancer	6.98e-07	6.84e-06	CbGpPWpGaD
Phenobarbital—CYP2C19—Metabolism—ERCC2—prostate cancer	6.95e-07	6.82e-06	CbGpPWpGaD
Phenobarbital—CYP2C18—Metabolism—PIK3CA—prostate cancer	6.9e-07	6.77e-06	CbGpPWpGaD
Phenobarbital—CYP2A6—Metabolism—PIK3CB—prostate cancer	6.9e-07	6.77e-06	CbGpPWpGaD
Phenobarbital—CYP3A4—Metabolism—CYP2A6—prostate cancer	6.9e-07	6.77e-06	CbGpPWpGaD
Phenobarbital—CYP1B1—Metabolism—EP300—prostate cancer	6.88e-07	6.74e-06	CbGpPWpGaD
Phenobarbital—CYP2B6—Metabolism—INS—prostate cancer	6.88e-07	6.74e-06	CbGpPWpGaD
Phenobarbital—CYP1A2—Metabolism—NCOA1—prostate cancer	6.88e-07	6.74e-06	CbGpPWpGaD
Phenobarbital—ABCB1—Metabolism—CYP1A1—prostate cancer	6.84e-07	6.71e-06	CbGpPWpGaD
Phenobarbital—ABCC1—Disease—KRAS—prostate cancer	6.84e-07	6.7e-06	CbGpPWpGaD
Phenobarbital—CYP2A6—Metabolism—PTGS2—prostate cancer	6.84e-07	6.7e-06	CbGpPWpGaD
Phenobarbital—CYP2C9—Metabolism—TYMS—prostate cancer	6.82e-07	6.69e-06	CbGpPWpGaD
Phenobarbital—ABCB1—Metabolism—ERCC2—prostate cancer	6.79e-07	6.65e-06	CbGpPWpGaD
Phenobarbital—CYP1A2—Metabolism—CYP19A1—prostate cancer	6.78e-07	6.64e-06	CbGpPWpGaD
Phenobarbital—CYP2C8—Metabolism—CAV1—prostate cancer	6.75e-07	6.62e-06	CbGpPWpGaD
Phenobarbital—CYP2C9—Metabolism—GSTM1—prostate cancer	6.74e-07	6.61e-06	CbGpPWpGaD
Phenobarbital—CYP2B6—Metabolism—CREBBP—prostate cancer	6.74e-07	6.6e-06	CbGpPWpGaD
Phenobarbital—CYP2E1—Metabolism—INS—prostate cancer	6.74e-07	6.6e-06	CbGpPWpGaD
Phenobarbital—CYP3A5—Metabolism—INS—prostate cancer	6.72e-07	6.59e-06	CbGpPWpGaD
Phenobarbital—ABCC3—Metabolism—PIK3CA—prostate cancer	6.72e-07	6.58e-06	CbGpPWpGaD
Phenobarbital—CYP3A4—Metabolism—AKR1C3—prostate cancer	6.71e-07	6.58e-06	CbGpPWpGaD
Phenobarbital—CYP1A1—Metabolism—PIK3CG—prostate cancer	6.71e-07	6.58e-06	CbGpPWpGaD
Phenobarbital—CYP3A4—Metabolism—PRKACB—prostate cancer	6.68e-07	6.55e-06	CbGpPWpGaD
Phenobarbital—CYP2C9—Metabolism—LPL—prostate cancer	6.62e-07	6.49e-06	CbGpPWpGaD
Phenobarbital—CYP3A4—Metabolism—CYP17A1—prostate cancer	6.61e-07	6.48e-06	CbGpPWpGaD
Phenobarbital—CYP2E1—Metabolism—CREBBP—prostate cancer	6.6e-07	6.47e-06	CbGpPWpGaD
Phenobarbital—CYP3A5—Metabolism—CREBBP—prostate cancer	6.59e-07	6.46e-06	CbGpPWpGaD
Phenobarbital—CYP1A2—Metabolism—RXRA—prostate cancer	6.54e-07	6.41e-06	CbGpPWpGaD
Phenobarbital—CYP2C19—Metabolism—MTHFR—prostate cancer	6.54e-07	6.41e-06	CbGpPWpGaD
Phenobarbital—CYP3A7—Metabolism—PTEN—prostate cancer	6.51e-07	6.38e-06	CbGpPWpGaD
Phenobarbital—CYP2C8—Metabolism of lipids and lipoproteins—PIK3CA—prostate cancer	6.45e-07	6.33e-06	CbGpPWpGaD
Phenobarbital—CYP4A11—Metabolism—AKT1—prostate cancer	6.45e-07	6.33e-06	CbGpPWpGaD
Phenobarbital—CYP2C19—Metabolism—PPARA—prostate cancer	6.41e-07	6.29e-06	CbGpPWpGaD
Phenobarbital—CYP2C9—Metabolism—CYP1A1—prostate cancer	6.39e-07	6.27e-06	CbGpPWpGaD
Phenobarbital—CYP2B6—Metabolism—PIK3CD—prostate cancer	6.39e-07	6.26e-06	CbGpPWpGaD
Phenobarbital—ABCB1—Metabolism—MTHFR—prostate cancer	6.38e-07	6.25e-06	CbGpPWpGaD
Phenobarbital—CYP1A2—Metabolism of lipids and lipoproteins—PTEN—prostate cancer	6.36e-07	6.24e-06	CbGpPWpGaD
Phenobarbital—CYP1A1—Metabolism—INS—prostate cancer	6.35e-07	6.23e-06	CbGpPWpGaD
Phenobarbital—CYP2C9—Metabolism—ERCC2—prostate cancer	6.34e-07	6.21e-06	CbGpPWpGaD
Phenobarbital—CYP1A2—Metabolism—COMT—prostate cancer	6.3e-07	6.18e-06	CbGpPWpGaD
Phenobarbital—CYP3A4—Metabolism—NCOA2—prostate cancer	6.3e-07	6.17e-06	CbGpPWpGaD
Phenobarbital—ABCC1—Disease—PIK3CA—prostate cancer	6.28e-07	6.16e-06	CbGpPWpGaD
Phenobarbital—CYP1A2—Metabolism—GSTP1—prostate cancer	6.27e-07	6.15e-06	CbGpPWpGaD
Phenobarbital—ABCB1—Metabolism—PPARA—prostate cancer	6.26e-07	6.13e-06	CbGpPWpGaD
Phenobarbital—CYP2E1—Metabolism—PIK3CD—prostate cancer	6.26e-07	6.13e-06	CbGpPWpGaD
Phenobarbital—CYP3A5—Metabolism—PIK3CD—prostate cancer	6.24e-07	6.12e-06	CbGpPWpGaD
Phenobarbital—CYP1A1—Metabolism—CREBBP—prostate cancer	6.22e-07	6.1e-06	CbGpPWpGaD
Phenobarbital—CYP3A7—Metabolism—EP300—prostate cancer	6.2e-07	6.08e-06	CbGpPWpGaD
Phenobarbital—CYP1A2—Metabolism—ITPR1—prostate cancer	6.17e-07	6.05e-06	CbGpPWpGaD
Phenobarbital—CYP2C8—Metabolism—PIK3CG—prostate cancer	6.15e-07	6.03e-06	CbGpPWpGaD
Phenobarbital—CYP1A2—Metabolism of lipids and lipoproteins—EP300—prostate cancer	6.07e-07	5.95e-06	CbGpPWpGaD
Phenobarbital—CYP2B6—Metabolism—NOS3—prostate cancer	6.03e-07	5.91e-06	CbGpPWpGaD
Phenobarbital—CYP2C19—Metabolism—CAV1—prostate cancer	6.03e-07	5.91e-06	CbGpPWpGaD
Phenobarbital—CYP3A4—Metabolism—SLC5A5—prostate cancer	6.01e-07	5.89e-06	CbGpPWpGaD
Phenobarbital—CYP2A6—Metabolism—PTEN—prostate cancer	5.96e-07	5.85e-06	CbGpPWpGaD
Phenobarbital—CYP2C9—Metabolism—MTHFR—prostate cancer	5.96e-07	5.84e-06	CbGpPWpGaD
Phenobarbital—CYP2E1—Metabolism—NOS3—prostate cancer	5.91e-07	5.79e-06	CbGpPWpGaD
Phenobarbital—CYP1A1—Metabolism—PIK3CD—prostate cancer	5.9e-07	5.78e-06	CbGpPWpGaD
Phenobarbital—CYP3A5—Metabolism—NOS3—prostate cancer	5.9e-07	5.78e-06	CbGpPWpGaD
Phenobarbital—ABCB1—Metabolism—CAV1—prostate cancer	5.88e-07	5.77e-06	CbGpPWpGaD
Phenobarbital—CYP3A4—Metabolism—CYP2E1—prostate cancer	5.87e-07	5.75e-06	CbGpPWpGaD
Phenobarbital—CYP2C9—Metabolism—PPARA—prostate cancer	5.85e-07	5.73e-06	CbGpPWpGaD
Phenobarbital—CYP1A2—Metabolism—TYMS—prostate cancer	5.83e-07	5.71e-06	CbGpPWpGaD
Phenobarbital—CYP2C8—Metabolism—INS—prostate cancer	5.82e-07	5.71e-06	CbGpPWpGaD
Phenobarbital—CYP3A4—Metabolism—NQO1—prostate cancer	5.8e-07	5.69e-06	CbGpPWpGaD
Phenobarbital—CYP1A2—Metabolism—GSTM1—prostate cancer	5.76e-07	5.65e-06	CbGpPWpGaD
Phenobarbital—CYP2C19—Metabolism of lipids and lipoproteins—PIK3CA—prostate cancer	5.76e-07	5.65e-06	CbGpPWpGaD
Phenobarbital—ABCB11—Metabolism—AKT1—prostate cancer	5.72e-07	5.61e-06	CbGpPWpGaD
Phenobarbital—CYP3A4—Metabolism—TH—prostate cancer	5.72e-07	5.61e-06	CbGpPWpGaD
Phenobarbital—CYP2C8—Metabolism—CREBBP—prostate cancer	5.7e-07	5.59e-06	CbGpPWpGaD
Phenobarbital—CYP2A6—Metabolism—EP300—prostate cancer	5.69e-07	5.57e-06	CbGpPWpGaD
Phenobarbital—CYP1A2—Metabolism—LPL—prostate cancer	5.66e-07	5.54e-06	CbGpPWpGaD
Phenobarbital—CYP2C18—Metabolism—AKT1—prostate cancer	5.64e-07	5.53e-06	CbGpPWpGaD
Phenobarbital—CYP1A1—Metabolism—NOS3—prostate cancer	5.57e-07	5.46e-06	CbGpPWpGaD
Phenobarbital—CYP2B6—Metabolism—PIK3CB—prostate cancer	5.57e-07	5.46e-06	CbGpPWpGaD
Phenobarbital—ABCC1—Disease—IL6—prostate cancer	5.56e-07	5.45e-06	CbGpPWpGaD
Phenobarbital—CYP3A4—Metabolism—CYP1B1—prostate cancer	5.56e-07	5.45e-06	CbGpPWpGaD
Phenobarbital—CYP2B6—Metabolism—PTGS2—prostate cancer	5.52e-07	5.41e-06	CbGpPWpGaD
Phenobarbital—CYP2C9—Metabolism—CAV1—prostate cancer	5.5e-07	5.39e-06	CbGpPWpGaD
Phenobarbital—CYP2C19—Metabolism—PIK3CG—prostate cancer	5.49e-07	5.38e-06	CbGpPWpGaD
Phenobarbital—ABCC3—Metabolism—AKT1—prostate cancer	5.49e-07	5.38e-06	CbGpPWpGaD
Phenobarbital—CYP1A2—Metabolism—CYP1A1—prostate cancer	5.46e-07	5.35e-06	CbGpPWpGaD
Phenobarbital—CYP2E1—Metabolism—PIK3CB—prostate cancer	5.45e-07	5.35e-06	CbGpPWpGaD
Phenobarbital—CYP3A5—Metabolism—PIK3CB—prostate cancer	5.44e-07	5.34e-06	CbGpPWpGaD
Phenobarbital—CYP1A2—Metabolism—ERCC2—prostate cancer	5.42e-07	5.31e-06	CbGpPWpGaD
Phenobarbital—CYP2C8—Metabolism—PIK3CD—prostate cancer	5.41e-07	5.3e-06	CbGpPWpGaD
Phenobarbital—CYP2E1—Metabolism—PTGS2—prostate cancer	5.4e-07	5.3e-06	CbGpPWpGaD
Phenobarbital—CYP3A5—Metabolism—PTGS2—prostate cancer	5.39e-07	5.29e-06	CbGpPWpGaD
Phenobarbital—CYP3A4—Metabolism—GGT1—prostate cancer	5.39e-07	5.28e-06	CbGpPWpGaD
Phenobarbital—ABCB1—Metabolism—PIK3CG—prostate cancer	5.36e-07	5.25e-06	CbGpPWpGaD
Phenobarbital—CYP3A4—Metabolism—NCOA1—prostate cancer	5.31e-07	5.2e-06	CbGpPWpGaD
Phenobarbital—ABCC1—Metabolism—PIK3CA—prostate cancer	5.26e-07	5.16e-06	CbGpPWpGaD
Phenobarbital—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CA—prostate cancer	5.25e-07	5.15e-06	CbGpPWpGaD
Phenobarbital—CYP3A4—Metabolism—CYP19A1—prostate cancer	5.23e-07	5.13e-06	CbGpPWpGaD
Phenobarbital—CYP2C19—Metabolism—INS—prostate cancer	5.2e-07	5.1e-06	CbGpPWpGaD
Phenobarbital—CYP1A1—Metabolism—PIK3CB—prostate cancer	5.14e-07	5.04e-06	CbGpPWpGaD
Phenobarbital—ABCC1—Disease—AKT1—prostate cancer	5.13e-07	5.03e-06	CbGpPWpGaD
Phenobarbital—CYP2C8—Metabolism—NOS3—prostate cancer	5.11e-07	5.01e-06	CbGpPWpGaD
Phenobarbital—CYP1A1—Metabolism—PTGS2—prostate cancer	5.09e-07	4.99e-06	CbGpPWpGaD
Phenobarbital—CYP1A2—Metabolism—MTHFR—prostate cancer	5.09e-07	4.99e-06	CbGpPWpGaD
Phenobarbital—CYP2C19—Metabolism—CREBBP—prostate cancer	5.09e-07	4.99e-06	CbGpPWpGaD
Phenobarbital—CYP1B1—Metabolism—PIK3CA—prostate cancer	5.09e-07	4.99e-06	CbGpPWpGaD
Phenobarbital—ABCB1—Metabolism—INS—prostate cancer	5.07e-07	4.97e-06	CbGpPWpGaD
Phenobarbital—CYP3A4—Metabolism—RXRA—prostate cancer	5.05e-07	4.95e-06	CbGpPWpGaD
Phenobarbital—CYP2C9—Metabolism—PIK3CG—prostate cancer	5.01e-07	4.91e-06	CbGpPWpGaD
Phenobarbital—CYP1A2—Metabolism—PPARA—prostate cancer	5e-07	4.9e-06	CbGpPWpGaD
Phenobarbital—ABCB1—Metabolism—CREBBP—prostate cancer	4.97e-07	4.87e-06	CbGpPWpGaD
Phenobarbital—CYP3A4—Metabolism—COMT—prostate cancer	4.86e-07	4.77e-06	CbGpPWpGaD
Phenobarbital—CYP3A4—Metabolism—GSTP1—prostate cancer	4.84e-07	4.74e-06	CbGpPWpGaD
Phenobarbital—CYP2C19—Metabolism—PIK3CD—prostate cancer	4.83e-07	4.73e-06	CbGpPWpGaD
Phenobarbital—CYP2B6—Metabolism—PTEN—prostate cancer	4.81e-07	4.72e-06	CbGpPWpGaD
Phenobarbital—CYP3A4—Metabolism—ITPR1—prostate cancer	4.76e-07	4.67e-06	CbGpPWpGaD
Phenobarbital—CYP2C9—Metabolism—INS—prostate cancer	4.74e-07	4.65e-06	CbGpPWpGaD
Phenobarbital—CYP2C8—Metabolism—PIK3CB—prostate cancer	4.71e-07	4.62e-06	CbGpPWpGaD
Phenobarbital—CYP2E1—Metabolism—PTEN—prostate cancer	4.71e-07	4.62e-06	CbGpPWpGaD
Phenobarbital—ABCB1—Metabolism—PIK3CD—prostate cancer	4.71e-07	4.62e-06	CbGpPWpGaD
Phenobarbital—CYP3A5—Metabolism—PTEN—prostate cancer	4.7e-07	4.61e-06	CbGpPWpGaD
Phenobarbital—CYP1A2—Metabolism—CAV1—prostate cancer	4.7e-07	4.6e-06	CbGpPWpGaD
Phenobarbital—CYP2C8—Metabolism—PTGS2—prostate cancer	4.67e-07	4.58e-06	CbGpPWpGaD
Phenobarbital—CYP2C9—Metabolism—CREBBP—prostate cancer	4.64e-07	4.55e-06	CbGpPWpGaD
Phenobarbital—CYP3A7—Metabolism—PIK3CA—prostate cancer	4.59e-07	4.5e-06	CbGpPWpGaD
Phenobarbital—CYP2B6—Metabolism—EP300—prostate cancer	4.59e-07	4.5e-06	CbGpPWpGaD
Phenobarbital—CYP2C19—Metabolism—NOS3—prostate cancer	4.56e-07	4.47e-06	CbGpPWpGaD
Phenobarbital—CYP3A4—Metabolism—TYMS—prostate cancer	4.5e-07	4.41e-06	CbGpPWpGaD
Phenobarbital—CYP2E1—Metabolism—EP300—prostate cancer	4.49e-07	4.41e-06	CbGpPWpGaD
Phenobarbital—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CA—prostate cancer	4.49e-07	4.4e-06	CbGpPWpGaD
Phenobarbital—CYP3A5—Metabolism—EP300—prostate cancer	4.49e-07	4.4e-06	CbGpPWpGaD
Phenobarbital—ABCB1—Metabolism—NOS3—prostate cancer	4.45e-07	4.36e-06	CbGpPWpGaD
Phenobarbital—CYP3A4—Metabolism—GSTM1—prostate cancer	4.45e-07	4.36e-06	CbGpPWpGaD
Phenobarbital—CYP1A1—Metabolism—PTEN—prostate cancer	4.44e-07	4.36e-06	CbGpPWpGaD
Phenobarbital—CYP2C9—Metabolism—PIK3CD—prostate cancer	4.4e-07	4.31e-06	CbGpPWpGaD
Phenobarbital—CYP3A4—Metabolism—LPL—prostate cancer	4.37e-07	4.28e-06	CbGpPWpGaD
Phenobarbital—ABCC1—Metabolism—AKT1—prostate cancer	4.3e-07	4.21e-06	CbGpPWpGaD
Phenobarbital—CYP1A2—Metabolism—PIK3CG—prostate cancer	4.28e-07	4.19e-06	CbGpPWpGaD
Phenobarbital—CYP1A1—Metabolism—EP300—prostate cancer	4.24e-07	4.15e-06	CbGpPWpGaD
Phenobarbital—CYP3A4—Metabolism—CYP1A1—prostate cancer	4.22e-07	4.13e-06	CbGpPWpGaD
Phenobarbital—CYP2C19—Metabolism—PIK3CB—prostate cancer	4.21e-07	4.12e-06	CbGpPWpGaD
Phenobarbital—CYP2A6—Metabolism—PIK3CA—prostate cancer	4.21e-07	4.12e-06	CbGpPWpGaD
Phenobarbital—CYP3A4—Metabolism—ERCC2—prostate cancer	4.18e-07	4.1e-06	CbGpPWpGaD
Phenobarbital—CYP2C19—Metabolism—PTGS2—prostate cancer	4.17e-07	4.09e-06	CbGpPWpGaD
Phenobarbital—CYP1B1—Metabolism—AKT1—prostate cancer	4.16e-07	4.08e-06	CbGpPWpGaD
Phenobarbital—CYP2C9—Metabolism—NOS3—prostate cancer	4.16e-07	4.07e-06	CbGpPWpGaD
Phenobarbital—ABCB1—Metabolism—PIK3CB—prostate cancer	4.11e-07	4.03e-06	CbGpPWpGaD
Phenobarbital—CYP2C8—Metabolism—PTEN—prostate cancer	4.07e-07	3.99e-06	CbGpPWpGaD
Phenobarbital—ABCB1—Metabolism—PTGS2—prostate cancer	4.07e-07	3.99e-06	CbGpPWpGaD
Phenobarbital—CYP1A2—Metabolism—INS—prostate cancer	4.05e-07	3.97e-06	CbGpPWpGaD
Phenobarbital—CYP1A2—Metabolism—CREBBP—prostate cancer	3.97e-07	3.89e-06	CbGpPWpGaD
Phenobarbital—CYP3A4—Metabolism—MTHFR—prostate cancer	3.93e-07	3.85e-06	CbGpPWpGaD
Phenobarbital—CYP2C8—Metabolism—EP300—prostate cancer	3.88e-07	3.81e-06	CbGpPWpGaD
Phenobarbital—CYP3A4—Metabolism—PPARA—prostate cancer	3.86e-07	3.78e-06	CbGpPWpGaD
Phenobarbital—CYP2C9—Metabolism—PIK3CB—prostate cancer	3.84e-07	3.76e-06	CbGpPWpGaD
Phenobarbital—CYP2C9—Metabolism—PTGS2—prostate cancer	3.8e-07	3.73e-06	CbGpPWpGaD
Phenobarbital—CYP1A2—Metabolism—PIK3CD—prostate cancer	3.76e-07	3.69e-06	CbGpPWpGaD
Phenobarbital—CYP3A7—Metabolism—AKT1—prostate cancer	3.75e-07	3.68e-06	CbGpPWpGaD
Phenobarbital—CYP2C19—Metabolism—PTEN—prostate cancer	3.64e-07	3.56e-06	CbGpPWpGaD
Phenobarbital—CYP3A4—Metabolism—CAV1—prostate cancer	3.63e-07	3.55e-06	CbGpPWpGaD
Phenobarbital—CYP1A2—Metabolism—NOS3—prostate cancer	3.55e-07	3.48e-06	CbGpPWpGaD
Phenobarbital—ABCB1—Metabolism—PTEN—prostate cancer	3.55e-07	3.48e-06	CbGpPWpGaD
Phenobarbital—CYP2C19—Metabolism—EP300—prostate cancer	3.47e-07	3.4e-06	CbGpPWpGaD
Phenobarbital—CYP2A6—Metabolism—AKT1—prostate cancer	3.44e-07	3.37e-06	CbGpPWpGaD
Phenobarbital—CYP2B6—Metabolism—PIK3CA—prostate cancer	3.39e-07	3.33e-06	CbGpPWpGaD
Phenobarbital—ABCB1—Metabolism—EP300—prostate cancer	3.38e-07	3.32e-06	CbGpPWpGaD
Phenobarbital—CYP2E1—Metabolism—PIK3CA—prostate cancer	3.32e-07	3.26e-06	CbGpPWpGaD
Phenobarbital—CYP3A5—Metabolism—PIK3CA—prostate cancer	3.32e-07	3.25e-06	CbGpPWpGaD
Phenobarbital—CYP2C9—Metabolism—PTEN—prostate cancer	3.32e-07	3.25e-06	CbGpPWpGaD
Phenobarbital—CYP3A4—Metabolism—PIK3CG—prostate cancer	3.3e-07	3.24e-06	CbGpPWpGaD
Phenobarbital—CYP1A2—Metabolism—PIK3CB—prostate cancer	3.28e-07	3.21e-06	CbGpPWpGaD
Phenobarbital—CYP1A2—Metabolism—PTGS2—prostate cancer	3.25e-07	3.18e-06	CbGpPWpGaD
Phenobarbital—CYP2C9—Metabolism—EP300—prostate cancer	3.16e-07	3.1e-06	CbGpPWpGaD
Phenobarbital—CYP1A1—Metabolism—PIK3CA—prostate cancer	3.13e-07	3.07e-06	CbGpPWpGaD
Phenobarbital—CYP3A4—Metabolism—INS—prostate cancer	3.13e-07	3.06e-06	CbGpPWpGaD
Phenobarbital—CYP3A4—Metabolism—CREBBP—prostate cancer	3.06e-07	3e-06	CbGpPWpGaD
Phenobarbital—CYP3A4—Metabolism—PIK3CD—prostate cancer	2.9e-07	2.85e-06	CbGpPWpGaD
Phenobarbital—CYP2C8—Metabolism—PIK3CA—prostate cancer	2.87e-07	2.82e-06	CbGpPWpGaD
Phenobarbital—CYP1A2—Metabolism—PTEN—prostate cancer	2.83e-07	2.78e-06	CbGpPWpGaD
Phenobarbital—CYP2B6—Metabolism—AKT1—prostate cancer	2.77e-07	2.72e-06	CbGpPWpGaD
Phenobarbital—CYP3A4—Metabolism—NOS3—prostate cancer	2.74e-07	2.69e-06	CbGpPWpGaD
Phenobarbital—CYP2E1—Metabolism—AKT1—prostate cancer	2.72e-07	2.66e-06	CbGpPWpGaD
Phenobarbital—CYP3A5—Metabolism—AKT1—prostate cancer	2.71e-07	2.66e-06	CbGpPWpGaD
Phenobarbital—CYP1A2—Metabolism—EP300—prostate cancer	2.7e-07	2.65e-06	CbGpPWpGaD
Phenobarbital—CYP2C19—Metabolism—PIK3CA—prostate cancer	2.57e-07	2.51e-06	CbGpPWpGaD
Phenobarbital—CYP1A1—Metabolism—AKT1—prostate cancer	2.56e-07	2.51e-06	CbGpPWpGaD
Phenobarbital—CYP3A4—Metabolism—PIK3CB—prostate cancer	2.53e-07	2.48e-06	CbGpPWpGaD
Phenobarbital—CYP3A4—Metabolism—PTGS2—prostate cancer	2.51e-07	2.46e-06	CbGpPWpGaD
Phenobarbital—ABCB1—Metabolism—PIK3CA—prostate cancer	2.5e-07	2.45e-06	CbGpPWpGaD
Phenobarbital—CYP2C8—Metabolism—AKT1—prostate cancer	2.35e-07	2.3e-06	CbGpPWpGaD
Phenobarbital—CYP2C9—Metabolism—PIK3CA—prostate cancer	2.34e-07	2.29e-06	CbGpPWpGaD
Phenobarbital—CYP3A4—Metabolism—PTEN—prostate cancer	2.19e-07	2.14e-06	CbGpPWpGaD
Phenobarbital—CYP2C19—Metabolism—AKT1—prostate cancer	2.1e-07	2.05e-06	CbGpPWpGaD
Phenobarbital—CYP3A4—Metabolism—EP300—prostate cancer	2.09e-07	2.04e-06	CbGpPWpGaD
Phenobarbital—ABCB1—Metabolism—AKT1—prostate cancer	2.05e-07	2e-06	CbGpPWpGaD
Phenobarbital—CYP1A2—Metabolism—PIK3CA—prostate cancer	2e-07	1.96e-06	CbGpPWpGaD
Phenobarbital—CYP2C9—Metabolism—AKT1—prostate cancer	1.91e-07	1.87e-06	CbGpPWpGaD
Phenobarbital—CYP1A2—Metabolism—AKT1—prostate cancer	1.63e-07	1.6e-06	CbGpPWpGaD
Phenobarbital—CYP3A4—Metabolism—PIK3CA—prostate cancer	1.54e-07	1.51e-06	CbGpPWpGaD
Phenobarbital—CYP3A4—Metabolism—AKT1—prostate cancer	1.26e-07	1.24e-06	CbGpPWpGaD
